Moleculin Biotech, Inc. (MBRX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Moleculin Biotech, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -1.17x | -0.27x | -0.85x | -1.04x | -3.15x | -2.71x |
| P/B Ratio | 2.61x | 0.98x | 0.98x | 0.58x | 0.63x | 2.63x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 1.41x | 0.97x | 3.86x | 9.46x | 20.02x | 5.89x |
| Quick Ratio | 1.41x | 0.97x | 3.86x | 9.46x | 20.02x | 5.89x |
| Leverage | ||||||
| Debt/Equity | 0.02x | 0.08x | 0.02x | 0.01x | 0.00x | 0.02x |
YoY = year-over-year change. Source: FMP..